Home · Compare

Helen I. Torley vs Mayukh Sukhatme

💰 How does your salary compare?

See how you rank against the world's top executives — free, instant, SEC-backed data

Mayukh Sukhatme earned $228.7M (987%) more than Helen I. Torley in their most recent fiscal years on record.

Helen I. TorleyMayukh Sukhatme

CompanyHalozyme TherapeuticsRoivant Sciences

TitleExecutive OfficerPresident and Chief Investment Officer

IndustryHealthcareHealthcare

Fiscal YearFY2025FY2024

Total Pay$23.2M$251.9M

Base Salary$1.0M$550,000

Stock Awards$21.0M$170.2M

Bonus—$81.1M

Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.

← Back to database · Helen I. Torley's full profile · Mayukh Sukhatme's full profile

ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy